NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Lars French, MD

Advertisement

Articles by Lars French, MD

Lars French, MD: Turning Global Skin Health Policy into Action for Patients

ByEmma Andrus, Editor,Lars French, MD
July 22nd 2025

Lars French, MD, explains how the new WHA resolution on skin health could drive training, access, and global policy change.

Advertisement

Latest Updated Articles

  • Lars French, MD: Turning Global Skin Health Policy into Action for Patients
    Lars French, MD: Turning Global Skin Health Policy into Action for Patients

    Published: July 22nd 2025 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib

2

FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus

3

Litifilimab Shows Early Skin Benefits in CLE

4

Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata

5

Modern, Multi-Modal Approaches to Repigmentation in Patients with Vitiligo

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us